Investigating the treatment of vascular risk with simvastatin in secondary progressive multiple sclerosis: analysis from the MS-STAT2 randomized controlled trial.
Williams T, Magill N, John NA, Bianchi A, Blackstone J, Braisher M, De Angelis F, Calvi A, Mangion S A, Wade C, et al.
